Jan 15 (Reuters) - ONCOLOGY VENTURE SWEDEN AB:
* ONCOLOGY VENTURE WILL EXECUTE LICENSE TO MULTI TKI PHASE 3 COMPOUND
* ‍NO FURTHER DETAILS HAVE BEEN DISCLOSED ON FINANCIAL CONTENT OF DEAL​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 